-
Notifications
You must be signed in to change notification settings - Fork 44
New issue
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.
By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.
Already on GitHub? Sign in to your account
FAD/Ubiquinone Duplicate Reactions #607
Comments
Really nice work @Devlin-Moyer. What do you think about the fact that by removing the direct ubiquinone-reducing reaction, the mechanism can instead use another electron acceptor to oxidize FADH2? I assume the direct ubiquinone-reducing versions were formulated to explicitly assign ubiquinone as the electron acceptor (likely to represent enzymes acting in the mitochondrial membrane), but the separation into 2 steps allows FADH2 oxidation by other means, such as:
I haven't investigated in detail, so maybe these "alternatives" are actually dead-ends that don't work, or end up using ubiquinone anyway? |
As I just mentioned over in #609, allowing FAD(H2) to move freely between any human FAD-dependent enzymes may be an accurate representation of reality: #609 (comment) Although I now notice that SDHA is listed as one of the only the 6 human flavoenzymes that covalently bind their FAD, and SDHA catalyzes |
Also the other three examples you listed are all catalyzed by enzymes that transfer electrons from their FAD cofactors to ETF, as discussed in #608, and since ETF is free to diffuse throughout the mitochondrial matrix and is clearly capable of reversible redox of its FAD cofactor, allowing transfer of FAD(H2) between reactions associated with those enzymes in particular may not be particularly unrealistic |
Sounds like a reasonable approach.
Agreed, thanks again for the helpful responses. |
For these pairs of reactions, I assume the GPRs have been checked and confirmed the association to FAD, instead of ubiquinone @Devlin-Moyer? Will there be other suggested changes to their GPRs than removal of peroxisomal ones (e.g. ACOX1 and ACOX3)? |
Yea if you look up any of the genes currently mentioned in these GPRs on Uniprot, they all say they have an FAD cofactor. It turns out ACOX1 and ACOX3 are also associated with a number of other mitochondrial reactions, so I'm working on a separate issue to identify all of those reactions and remove ACOX1 and ACOX3 (it's complicated by the fact that ACOX1 and ACOX3 are the only genes associated with some mitochondrial reactions, so I'm trying to figure out if those reactions just don't happen in mitochondria or if some other enzyme actually localized to mitochondria catalyzes them) |
very good idea |
The Problem:
This is follow-up of what discussed in #599
These pairs of reactions all represent reactions that are catalyzed by enzymes that use FAD as a cofactor, and the electrons harvested from their substrates eventually make their way from FAD to ubiquinone, but Human-GEM currently has one version that involves FAD and another that directly reduces ubiquinone with no explicit acknowledgement of the role of FAD:
Aside from the last few reactions, if you look at any of the genes associated with any of these reactions, the overwhelming majority of other reactions associated with thse genes only have FAD-dependent versions (e.g. out of the 90 reactions ACADVL is associated with,
MAR02035
is the only one that uses ubiquinone instead of FAD), so for consistency, it would make sense to just drop the ubiquinone-dependent member of each of these pairs.Speaking of the genes associated with these reaction, some of them (e.g. ACOX1 and ACOX3) are peroxisomal and not mitochondrial, but they're also associated with a bunch of other mitochondrial reactions, so I'm making a separate issue about that.
I put this list together by manually looking into every reaction that involves ubiquinone; it probably could've been automated, but now that I've already done it manually, I don't see a reason to figure out how to automate it, since it's not clear if that automation would be applicable to any other situations that this issue wouldn't resolve.
Update: it turns out that
MAR03769
was the only reaction thatENSG00000128928
(Isovaleryl-CoA Dehydrogenase; IVD) was associated with, but it is clearly also appropriate to associate it withMAR03770
(see Uniprot), so in order to avoid making IVD no longer associated with any reactions by removingMAR03769
, it should be added to the GPR ofMAR03770
.Update: I found another pair like this (
MAR02369
andMAR03149
) and added it to the table above and list belowSuggested Changes:
MAR02035
for being a duplicate ofMAR03121
MAR03211
for being a duplicate ofMAR03212
MAR03751
for being a duplicate ofMAR03752
MAR03783
for being a duplicate ofMAR03784
MAR04242
for being a duplicate ofMAR04243
MAR03769
for being a duplicate ofMAR03770
MAR03838
for being a duplicate ofMAR08611
MAR02366
for being a duplicate ofMAR03136
MAR02367
for being a duplicate ofMAR03135
MAR02370
for being a duplicate ofMAR03128
MAR02372
for being a duplicate ofMAR03156
MAR02369
for being a duplicate ofMAR03149
MAR02373
for being a duplicate ofMAR03142
MAR00483
for being a duplicate ofMAR00482
/MAR00449
/MAR01169
(but this may already get taken care of in Proposed fixes to DHAP <=> sn-glycerol-3-phosphate reactions #599)MAR08743
for being a duplicate ofMAR04652
(only case where we're removing the FAD-dependent version and not the ubiquinone-dependent version, since this is the only reaction where the FAD is covalently bound to the enzyme catalyzing it and not in theory capable of dissociating from the enzyme between redox of the substrate and redox of ubiquinone)ENSG00000128928
to GPR ofMAR03770
so it is still associated with at least one reactionThe text was updated successfully, but these errors were encountered: